David Feifel
Professor Emeritus of Psychiatry at the University of California, San Diego; President of Kadima Neuropsychiatry Institute
Key Impact
David Feifel is a prominent psychiatrist and neuropsychiatrist who helped pioneer ketamine-based treatment programs and has coauthored clinical psychedelic research on psilocybin for treatment-resistant depression.
Background & Research
David Feifel earned B.Sc., M.A., M.D., and Ph.D. degrees in neurobiology from the University of Toronto and completed his psychiatry residency at UC San Diego. He became a professor in the UCSD Department of Psychiatry, where he directed the Neuropsychiatry and Behavioral Medicine Program and founded the Center for Advanced Treatment of Mood and Anxiety Disorders. He later founded Kadima Neuropsychiatry Institute in La Jolla and has remained active in ketamine, TMS, and psychedelic-treatment research.
Collaboration Network
27 collaborators· click a node to visit their profile
Full network →